1. Home
  2. ULY vs TSBX Comparison

ULY vs TSBX Comparison

Compare ULY & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • TSBX
  • Stock Information
  • Founded
  • ULY 2013
  • TSBX 2015
  • Country
  • ULY United States
  • TSBX United States
  • Employees
  • ULY N/A
  • TSBX N/A
  • Industry
  • ULY
  • TSBX
  • Sector
  • ULY
  • TSBX
  • Exchange
  • ULY Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • ULY 14.8M
  • TSBX 11.8M
  • IPO Year
  • ULY N/A
  • TSBX 2023
  • Fundamental
  • Price
  • ULY $0.65
  • TSBX $0.45
  • Analyst Decision
  • ULY Strong Buy
  • TSBX Strong Buy
  • Analyst Count
  • ULY 1
  • TSBX 2
  • Target Price
  • ULY $2.00
  • TSBX $6.88
  • AVG Volume (30 Days)
  • ULY 589.5K
  • TSBX 145.3K
  • Earning Date
  • ULY 11-12-2024
  • TSBX 11-07-2024
  • Dividend Yield
  • ULY N/A
  • TSBX N/A
  • EPS Growth
  • ULY N/A
  • TSBX N/A
  • EPS
  • ULY 7.76
  • TSBX N/A
  • Revenue
  • ULY $165,727,000.00
  • TSBX N/A
  • Revenue This Year
  • ULY N/A
  • TSBX N/A
  • Revenue Next Year
  • ULY $20.40
  • TSBX N/A
  • P/E Ratio
  • ULY $0.09
  • TSBX N/A
  • Revenue Growth
  • ULY N/A
  • TSBX N/A
  • 52 Week Low
  • ULY $0.64
  • TSBX $0.45
  • 52 Week High
  • ULY $12.00
  • TSBX $5.75
  • Technical
  • Relative Strength Index (RSI)
  • ULY 27.44
  • TSBX 16.75
  • Support Level
  • ULY $0.65
  • TSBX $0.58
  • Resistance Level
  • ULY $0.72
  • TSBX $0.70
  • Average True Range (ATR)
  • ULY 0.08
  • TSBX 0.05
  • MACD
  • ULY -0.00
  • TSBX 0.03
  • Stochastic Oscillator
  • ULY 2.89
  • TSBX 1.10

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: